Oncogenic B-RafV600E Inhibits Apoptosis and Promotes ERK-dependent Inactivation of Bad and Bim
Open Access
- 1 August 2008
- journal article
- Published by Elsevier BV
- Vol. 283 (32), 22128-22135
- https://doi.org/10.1074/jbc.m800271200
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cellsThe Journal of Experimental Medicine, 2006
- Apoptosomes: protease activation platforms to die fromTrends in Biochemical Sciences, 2006
- Double Knockout Blow for CaspasesScience, 2006
- Oncogenic BRAF Is Required for Tumor Growth and Maintenance in Melanoma ModelsCancer Research, 2006
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005
- Differential Regulation of Noxa in Normal Melanocytes and Melanoma Cells by Proteasome Inhibition: Therapeutic ImplicationsCancer Research, 2005
- Proteasome Inhibitors Trigger NOXA-Mediated Apoptosis in Melanoma and Myeloma CellsCancer Research, 2005
- Mitochondria: Releasing Power for Life and Unleashing the Machineries of DeathCell, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001